Imagen de portada del espectáculo Labcat.ai Read Alzheimer's Disease Paper

Labcat.ai Read Alzheimer's Disease Paper

Podcast de meng

inglés

Desarrollo personal & Salud

Oferta limitada

2 meses por 1 €

Después 4,99 € / mesCancela cuando quieras.

  • 20 horas de audiolibros / mes
  • Podcasts exclusivos
  • Podcast gratuitos
Empezar

Acerca de Labcat.ai Read Alzheimer's Disease Paper

• 🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor • 🏥 Clinical insights and how institutions are responding • 💡 Therapeutic innovations and emerging treatment targets • 🎯 Practical takeaways for physicians, neurologists, and medical researchers Get journal's impact factors at : https://www.journalmetrics.org Find clinical trials easily : https://www.clinicaltrialsfind.com Find NIH grants trend: https://www.gotgrant.com

Todos los episodios

207 episodios

Portada del episodio May 29, 2026 - Alzheimer Research Update

May 29, 2026 - Alzheimer Research Update

May 29, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Convergent mitochondrial impairment and apoptosis driven by simultaneous down-regulation of multiple genes at 11p11.2 in Alzheimer's disease. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

Ayer - 2 min
Portada del episodio May 28, 2026 - Alzheimer Research Update

May 28, 2026 - Alzheimer Research Update

May 28, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

28 de may de 2026 - 2 min
Portada del episodio May 27, 2026 - Alzheimer Research Update

May 27, 2026 - Alzheimer Research Update

May 27, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

27 de may de 2026 - 3 min
Portada del episodio May 26, 2026 - Alzheimer Research Update

May 26, 2026 - Alzheimer Research Update

May 26, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

26 de may de 2026 - 1 min
Portada del episodio May 25, 2026 - Alzheimer Research Update

May 25, 2026 - Alzheimer Research Update

May 25, 2026 - Latest Alzheimer Research Update Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches. Featured Paper: Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration. Key topics include: • The highest impact factor research published yesterday on PubMed • Clinical implications and institutional insights • Practical implications for medical professionals • Emerging therapeutic targets and treatment approaches Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more. Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments. #MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare

25 de may de 2026 - 2 min
Soy muy de podcasts. Mientras hago la cama, mientras recojo la casa, mientras trabajo… Y en Podimo encuentro podcast que me encantan. De emprendimiento, de salid, de humor… De lo que quiera! Estoy encantada 👍
Soy muy de podcasts. Mientras hago la cama, mientras recojo la casa, mientras trabajo… Y en Podimo encuentro podcast que me encantan. De emprendimiento, de salid, de humor… De lo que quiera! Estoy encantada 👍
MI TOC es feliz, que maravilla. Ordenador, limpio, sugerencias de categorías nuevas a explorar!!!
Me suscribi con los 14 días de prueba para escuchar el Podcast de Misterios Cotidianos, pero al final me quedo mas tiempo porque hacia tiempo que no me reía tanto. Tiene Podcast muy buenos y la aplicación funciona bien.
App ligera, eficiente, encuentras rápido tus podcast favoritos. Diseño sencillo y bonito. me gustó.
contenidos frescos e inteligentes
La App va francamente bien y el precio me parece muy justo para pagar a gente que nos da horas y horas de contenido. Espero poder seguir usándola asiduamente.

Elige tu suscripción

Más populares

Oferta limitada

Premium

20 horas de audiolibros

  • Podcasts exclusivos

  • Disfruta los podcast de Podimo sin anuncios

  • Cancela cuando quieras

2 meses por 1 €
Después 4,99 € / mes

Empezar

Premium Plus

100 horas de audiolibros

  • Podcasts exclusivos

  • Disfruta los podcast de Podimo sin anuncios

  • Cancela cuando quieras

Disfruta 30 días gratis
Después 9,99 € / mes

Prueba gratis

Sólo en Podimo

Audiolibros populares

Preguntas frecuentes

Más preguntas y respuestas
Empezar

2 meses por 1 €. Después 4,99 € / mes. Cancela cuando quieras.